Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Boulardii for HIV-Related Chronic Diarrhea
NCT00002088Phase 2Completed
- Sponsor
- Biocodex
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Chronic diarrhea comparing Saccharomyces boulardii with Placebo (2 arms). Primary endpoint: Reduction in diarrheal symptoms. Status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
Chronic diarrhea
Beyond the preview
Go deeper on NCT00002088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002088.